Pharmaceutical Product Commercialization

Increasing R&D costs, generic competition and fragile pipelines make the successful launch of new drugs critically important for pharmaceutical and biotechnology companies. Optimal resource allocation for the commercial development of emerging brands, however, continues to challenge companies across both sectors. This paper profiles one brand’s marketing expenditures and team headcounts throughout commercialization.